{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:04:22Z","timestamp":1773047062177,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MD Anderson Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Bacillus Calmette\u2013Guerin (BCG) vaccine provides protection against tuberculosis (TB), and is thought to provide protection against non-TB infectious diseases. BCG vaccination has recently been proposed as a strategy to prevent infection with SARS-CoV-2 (CoV-2) to combat the COVID-19 outbreak, supported by its potential to boost innate immunity and initial epidemiological analyses which observed reduced severity of COVID-19 in countries with universal BCG vaccination policies. Seventeen clinical trials are currently registered to inform on the benefits of BCG vaccinations upon exposure to CoV-2. Numerous epidemiological analyses showed a correlation between incidence of COVID-19 and BCG vaccination policies. These studies were not systematically corrected for confounding variables. We observed that after correction for confounding variables, most notably testing rates, there was no association between BCG vaccination policy and COVD-19 spread rate or percent mortality. Moreover, we found variables describing co-morbidities, including cardiovascular death rate and smoking prevalence, were significantly associated COVID-19 spread rate and percent mortality, respectively. While reporting biases may confound our observations, our epidemiological findings do not provide evidence to correlate overall BCG vaccination policy with the spread of CoV-2 and its associated mortality.<\/jats:p>","DOI":"10.1038\/s41598-020-75491-x","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:03:40Z","timestamp":1603796620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses"],"prefix":"10.1038","volume":"10","author":[{"given":"Janine","family":"Hensel","sequence":"first","affiliation":[]},{"given":"Kathleen M.","family":"McAndrews","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-6069","authenticated-orcid":false,"given":"Daniel J.","family":"McGrail","sequence":"additional","affiliation":[]},{"given":"Dara P.","family":"Dowlatshahi","sequence":"additional","affiliation":[]},{"given":"Valerie S.","family":"LeBleu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-547X","authenticated-orcid":false,"given":"Raghu","family":"Kalluri","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"75491_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","volume":"10","author":"R Tanner","year":"2019","unstructured":"Tanner, R., Villarreal-Ramos, B., Vordermeier, H. M. & McShane, H. The humoral immune response to BCG vaccination. Front. Immunol. 10, 1317. https:\/\/doi.org\/10.3389\/fimmu.2019.01317 (2019).","journal-title":"Front. Immunol."},{"key":"75491_CR2","doi-asserted-by":"publisher","first-page":"89 e105","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89 e105-100 e105. https:\/\/doi.org\/10.1016\/j.chom.2017.12.010 (2018).","journal-title":"Cell Host Microbe"},{"key":"75491_CR3","first-page":"20","volume":"20","author":"HM Dockrell","year":"2017","unstructured":"Dockrell, H. M. & Smith, S. G. What have we learnt about BCG vaccination in the last 20 years?. Front. Immunol. 20, 20 (2017).","journal-title":"Front. Immunol."},{"key":"75491_CR4","first-page":"20","volume":"20","author":"PHE Nguipdop-Djomo","year":"2016","unstructured":"Nguipdop-Djomo, P. H. E., Rodrigues, L. C., Abubakar, I. & Mangtani, P. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: A retrospective population-based cohort study. Lancet Infect. Dis. 20, 20 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"75491_CR5","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","volume":"291","author":"NE Aronson","year":"2004","unstructured":"Aronson, N. E. et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 291, 2086\u20132091. https:\/\/doi.org\/10.1001\/jama.291.17.2086 (2004).","journal-title":"JAMA"},{"key":"75491_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","volume":"159","author":"D Menzies","year":"1999","unstructured":"Menzies, D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am. J. Respir. Crit. Care Med. 159, 15\u201321. https:\/\/doi.org\/10.1164\/ajrccm.159.1.9801120 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"75491_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"S Moorlag","year":"2019","unstructured":"Moorlag, S., Arts, R. J. W., van Crevel, R. & Netea, M. G. Non-specific effects of BCG vaccine on viral infections. Clin. Microbiol. Infect. 25, 1473\u20131478. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.020 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"75491_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaci.2010.07.039","volume":"127","author":"DL Arnoldussen","year":"2011","unstructured":"Arnoldussen, D. L., Linehan, M. & Sheikh, A. BCG vaccination and allergy: A systematic review and meta-analysis. J. Allergy Clin. Immunol. 127, 246-253 e241\u2013221. https:\/\/doi.org\/10.1016\/j.jaci.2010.07.039 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"75491_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.051","author":"E Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. et al. ACTIVATE: Randomized clinical trial of BCG vaccination against infection in the elderly. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.08.051 (2020).","journal-title":"Cell"},{"key":"75491_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/thorax.55.10.867","volume":"55","author":"K Nakayama","year":"2000","unstructured":"Nakayama, K., Monma, M., Fukushima, T., Ohrui, T. & Sasaki, H. Tuberculin responses and risk of pneumonia in immobile elderly patients. Thorax 55, 867\u2013869. https:\/\/doi.org\/10.1136\/thorax.55.10.867 (2000).","journal-title":"Thorax"},{"key":"75491_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3143\/geriatrics.42.34","volume":"42","author":"T Ohrui","year":"2005","unstructured":"Ohrui, T., Nakayama, K., Fukushima, T., Chiba, H. & Sasaki, H. Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations. Nihon Ronen Igakkai Zasshi 42, 34\u201336. https:\/\/doi.org\/10.3143\/geriatrics.42.34 (2005).","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"75491_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.05.20123539","author":"DI Levine","year":"2020","unstructured":"Levine, D. I. A shred of evidence that BCG vaccine may protect against COVID-19: Comparing cohorts in Spain and Italy. medRxiv. https:\/\/doi.org\/10.1101\/2020.06.05.20123539 (2020).","journal-title":"medRxiv"},{"key":"75491_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","volume":"395","author":"N Curtis","year":"2020","unstructured":"Curtis, N., Sparrow, A., Ghebreyesus, T. A. & Netea, M. G. Considering BCG vaccination to reduce the impact of COVID-19. Lancet 395, 1545\u20131546. https:\/\/doi.org\/10.1016\/S0140-6736(20)31025-4 (2020).","journal-title":"Lancet"},{"key":"75491_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.01.20049478","author":"A Shet","year":"2020","unstructured":"Shet, A., Ray, D., Malavige, N., Santosham, M. & Bar-Zeev, N. Differential COVID-19-attributable mortality and BCG vaccine use in countries. medRxiv. https:\/\/doi.org\/10.1101\/2020.04.01.20049478 (2020).","journal-title":"medRxiv"},{"key":"75491_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.07.20053272","author":"D Dayal","year":"2020","unstructured":"Dayal, D. & Gupta, S. Connecting BCG Vaccination and COVID-19: Additional Data. medRxiv. https:\/\/doi.org\/10.1101\/2020.04.07.20053272 (2020).","journal-title":"medRxiv"},{"key":"75491_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20048165","author":"G Sala","year":"2020","unstructured":"Sala, G. & Miyakawa, T. Association of BCG vaccination policy with prevalence and mortality of COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2020.03.30.20048165 (2020).","journal-title":"medRxiv"},{"key":"75491_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042937","author":"A Miller","year":"2020","unstructured":"Miller, A. et al. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: An epidemiological study. medRxiv. https:\/\/doi.org\/10.1101\/2020.03.24.20042937 (2020).","journal-title":"medRxiv"},{"key":"75491_CR18","doi-asserted-by":"publisher","first-page":"17720","DOI":"10.1073\/pnas.2008410117","volume":"117","author":"LE Escobar","year":"2020","unstructured":"Escobar, L. E., Molina-Cruz, A. & Barillas-Mury, C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc. Natl. Acad. Sci. USA 117, 17720\u201317726. https:\/\/doi.org\/10.1073\/pnas.2008410117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75491_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Tracking Changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812-827 e819. https:\/\/doi.org\/10.1016\/j.cell.2020.06.043 (2020).","journal-title":"Cell"},{"key":"75491_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","volume":"53","author":"CA Devaux","year":"2020","unstructured":"Devaux, C. A., Rolain, J. M. & Raoult, D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J. Microbiol. Immunol. Infect. 53, 425\u2013435. https:\/\/doi.org\/10.1016\/j.jmii.2020.04.015 (2020).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"75491_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O'Neill","year":"2020","unstructured":"O\u2019Neill, L. A. J. & Netea, M. G. BCG-induced trained immunity: Can it offer protection against COVID-19?. Nat. Rev. Immunol. 20, 335\u2013337. https:\/\/doi.org\/10.1038\/s41577-020-0337-y (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"75491_CR22","unstructured":"Bluhm, R. & Pinkovskiy, M. The BCG Vaccine Does Not Protect Against COVID-19: Applying an Economist\u2019s Toolkit to a Medical Question. https:\/\/voxeu.org\/article\/bcg-vaccine-does-not-protect-against-covid-19 (2020)."},{"key":"75491_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa681","author":"ST Sehxra","year":"2020","unstructured":"Sehxra, S. T., Salciccioli, J. D., Wiebe, D. J., Fundin, S. & Baker, J. F. Maximum daily temperature, precipitation, ultra-violet light and rates of transmission of SARS-Cov-2 in the United States. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa681 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"75491_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1126\/science.abb4557","volume":"368","author":"BF Maier","year":"2020","unstructured":"Maier, B. F. & Brockmann, D. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Science 368, 742\u2013746. https:\/\/doi.org\/10.1126\/science.abb4557 (2020).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75491-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:20:29Z","timestamp":1670365229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75491-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75491"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75491-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18377"}}